Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259800 · ClinicalTrials.gov registry record · NA
Peppermint Oil for Urinary Retention
A NA study, sponsored by TriHealth.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05259800: Clinical Trial NA study, sponsored by TriHealth.
NCT05259800 is a NA study that was terminated before completion, run by TriHealth. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05259800, a NA study, was terminated before completion, sponsored by TriHealth.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
A randomized controlled study will be conducted, with two arms. Postpartum women experiencing urinary retention will be randomized into one of the two following arms: * Arm 1: Subjects will be exposed to vapor of peppermint oil * Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.
Primary Outcome
Urinary retention defined as: * More than 6 hours after delivery or foley catheter removal without being able to spontaneously void * Symptomatic urinary retention without being able to spontaneously void * Change in fundal height or position without being able to spontaneously void More than 6 hours after delivery or foley catheter removal without voiding spontaneously; symptomatic urinary retention without being able to spontaneously void; or change in fundal height or position without being
Interventions
- OTHER Peppermint oil vapors
- OTHER Mineral Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Why NCT05259800 stopped before completion
NCT05259800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Peppermint oil vapors is the first listed.
NCT05259800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05259800 about?
NCT05259800 is a clinical study titled "Peppermint Oil for Urinary Retention". A randomized controlled study will be conducted, with two arms. Postpartum women experiencing urinary retention will be randomized into one of the two following arms: * Arm 1: Subjects will be exposed to vapor of peppermint oil * Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Out...
What is the current status of trial NCT05259800?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2021-10-05. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT05259800?
The interventions under investigation include: Peppermint oil vapors (OTHER), Mineral Oil (OTHER).
Who is sponsoring clinical trial NCT05259800?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05259800's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI